268 related articles for article (PubMed ID: 25323242)
1. Inhaled antibiotics: dry or wet?
Tiddens HA; Bos AC; Mouton JW; Devadason S; Janssens HM
Eur Respir J; 2014 Nov; 44(5):1308-18. PubMed ID: 25323242
[TBL] [Abstract][Full Text] [Related]
2. Aerosolized antibiotics in cystic fibrosis: an update.
Fiel SB
Expert Rev Respir Med; 2014 Jun; 8(3):305-14. PubMed ID: 24838090
[TBL] [Abstract][Full Text] [Related]
3. The cost effectiveness of dry powder antibiotics for the treatment of Pseudomonas aeruginosa in patients with cystic fibrosis.
Tappenden P; Harnan S; Uttley L; Mildred M; Walshaw M; Taylor C; Brownlee K
Pharmacoeconomics; 2014 Feb; 32(2):159-72. PubMed ID: 24338264
[TBL] [Abstract][Full Text] [Related]
4. [Dry powder inhalers in cystic fibrosis].
Steinkamp G
Pneumologie; 2014 Jun; 68(6):378-85. PubMed ID: 24664997
[TBL] [Abstract][Full Text] [Related]
5. Estimating in vivo airway surface liquid concentration in trials of inhaled antibiotics.
Hasan MA; Lange CF
J Aerosol Med; 2007; 20(3):282-93. PubMed ID: 17894535
[TBL] [Abstract][Full Text] [Related]
6. Inhaled antibiotics to treat lung infection.
Cipolla D; Chan HK
Pharm Pat Anal; 2013 Sep; 2(5):647-63. PubMed ID: 24237172
[TBL] [Abstract][Full Text] [Related]
7. Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients.
Westerman EM; Heijerman HG; Frijlink HW
Expert Opin Drug Deliv; 2007 Mar; 4(2):91-4. PubMed ID: 17335406
[TBL] [Abstract][Full Text] [Related]
8. Dry powder inhalation of colistin in cystic fibrosis patients: a single dose pilot study.
Westerman EM; De Boer AH; Le Brun PP; Touw DJ; Roldaan AC; Frijlink HW; Heijerman HG
J Cyst Fibros; 2007 Jul; 6(4):284-92. PubMed ID: 17185047
[TBL] [Abstract][Full Text] [Related]
9. [Use of inhaled tobramycin in patients with cystic fibrosis].
Chermenskiĭ AG; Gembitskaia TE
Ter Arkh; 2010; 82(8):76-8. PubMed ID: 20873251
[TBL] [Abstract][Full Text] [Related]
10. Dry powder inhalers in cystic fibrosis: same old drugs but different benefits?
Uttley L; Tappenden P
Curr Opin Pulm Med; 2014 Nov; 20(6):607-12. PubMed ID: 25221853
[TBL] [Abstract][Full Text] [Related]
11. Optimal airway antimicrobial therapy for cystic fibrosis: the role of inhaled aztreonam lysine.
Elborn JS; Henig NR
Expert Opin Pharmacother; 2010 Jun; 11(8):1373-85. PubMed ID: 20426707
[TBL] [Abstract][Full Text] [Related]
12. Eradication of
Akkerman-Nijland AM; Yousofi M; Rottier BL; Van der Vaart H; Burgerhof JGM; Frijlink HW; Touw DJ; Koppelman GH; Akkerman OW
Ther Adv Respir Dis; 2020; 14():1753466620905279. PubMed ID: 32046620
[TBL] [Abstract][Full Text] [Related]
13. [Inhaled treatments in cystic fibrosis: what's new in 2013?].
Dubus JC; Bassinet L; Chedevergne F; Delaisi B; Desmazes-Dufeu N; Reychler G; Vecellio L;
Rev Mal Respir; 2014 Apr; 31(4):336-46. PubMed ID: 24750953
[TBL] [Abstract][Full Text] [Related]
14. [TOBI Podhaler for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis patients].
Pierart F
Rev Med Liege; 2013 Sep; 68(9):486-8. PubMed ID: 24180205
[TBL] [Abstract][Full Text] [Related]
15. Association between the introduction of a new cystic fibrosis inhaled antibiotic class and change in prevalence of patients receiving multiple inhaled antibiotic classes.
Dasenbrook EC; Konstan MW; VanDevanter DR
J Cyst Fibros; 2015 May; 14(3):370-5. PubMed ID: 25496726
[TBL] [Abstract][Full Text] [Related]
16. Inhaled antibiotics for lower airway infections.
Quon BS; Goss CH; Ramsey BW
Ann Am Thorac Soc; 2014 Mar; 11(3):425-34. PubMed ID: 24673698
[TBL] [Abstract][Full Text] [Related]
17. Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis.
Uttley L; Harnan S; Cantrell A; Taylor C; Walshaw M; Brownlee K; Tappenden P
Eur Respir Rev; 2013 Dec; 22(130):476-86. PubMed ID: 24293463
[TBL] [Abstract][Full Text] [Related]
18. [Anti-Pseudomonas aerosol therapy in cystic fibrosis: improvement with tobramycin].
Foucaud P; Borel B; Charara O; Nathanson S; Petitprez P; Pin I
Rev Pneumol Clin; 2002 Jun; 58(3 Pt 1):131-8. PubMed ID: 12486796
[TBL] [Abstract][Full Text] [Related]
19. A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis.
Littlewood KJ; Higashi K; Jansen JP; Capkun-Niggli G; Balp MM; Doering G; Tiddens HA; Angyalosi G
J Cyst Fibros; 2012 Sep; 11(5):419-26. PubMed ID: 22717535
[TBL] [Abstract][Full Text] [Related]
20. Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Parkins MD; Elborn JS
Expert Rev Respir Med; 2011 Oct; 5(5):609-22. PubMed ID: 21955231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]